Skip to content
Screener

Eli Lilly LLY Segment Reporting, Other Segment Item, Amount

Segment Reporting, Other Segment Item, Amount at other companies

ConocoPhillips logo
ConocoPhillipsCOP
$7.45B+42.3%
PRA Group logo
PRA GroupPRAA
$35.48M-6.5%
Matthews International logo
Matthews InternationalMATW
-$15.63M-883%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$25.48M+4,316%
Radiant Logistics logo
Radiant LogisticsRLGT
-$271K-113%
Microbot Medical logo
Microbot MedicalMBOT
$557K+7.3%

Segments

By segment

See full
Reportable Segment$2.59B+114%

Other financials

Income statement

See full
Revenue$23.0B+47.7%
Gross profit$19.7B+50.3%
Net income$7.1B+25.3%
EPS (diluted)$7.94+26.2%

Balance sheet

See full
Cash & equivalents$9.0B+165%
Total debt$54.9B+37.6%
Total equity$33.9B+85.4%
Total assets$142.28B+41.0%

Cash flow

See full
Operating cash flow$10.7B+246%
CapEx$2.9B+72.8%
Free cash flow$7.8B+458%

Valuation

See full
Market cap$1.06T+58.6%
Enterprise value$1.11T+56.9%
P/E39.8×-8.8×
P/S13.3×+0.8×

Profitability

See full
Gross margin83.4%+0.8pp
Net margin33.5%+7.6pp
FCF margin22.8%+13.7pp

Returns & leverage

See full
Return on equity102.4%+15.7pp
Debt / equity1.6×-0.6×
Current ratio1.4×+0.1×